Paediatric medications in 2024, availability and perspectives
| 08:30-09:00 | Welcome coffee |
| 09:00-09:20 | APGI Information and agenda |
| 09:20-10:00 | Regulatory framework and perspectives for the paediatric drug development in Europe Sylvie Benchetrit – Paediatric referent ANSM, PDCO Vice-Chair French Delegate Céline Chu – Paediatric coordinator ANSM |
| 10:00-10:40 | Management of iaotrogenic risk in paediatric patients Dr Anne-Laure Clairet – CHU Besançon |
| 10:40-11:10 | Coffee break |
| 11:10-11:50 | Off-label prescribing in paediatrics: overview, recommendations Prof. Florentia Kaguelidou – AP HP Nord, Université Paris Cité |
| 11:50-12:30 | Highlights on the uncovered needs – title to be confirmed Fabienne Benoist – DNDi |
| 12:30-13:40 | Lunch break |
| 13:40-14:20 | Design and conduct of drugs studies in children: challenges and opportunities Prof. Joseph F. Standing – Great Ormond Street Institute of Child Health, University College London |
| 14:20-15:00 | Development of acceptable paediatric formulation or how to align patients’ needs, formulators’ toolbox and regulators’ requirements Prof. Catherine Tuleu – Professor in Paeditric Pharmaceutics – University College London |
| 15:00-15:30 | Coffee break |
| 15:30-16:10 | 3D Printing for Personalized Treatment in Paediatrics Carlos Javier Parramon Teixido, Hospital Pharmacist – Val d’Ebron Barcelona Hospital Campus |
| 16:10-17:00 | Feedback on development experiences of paediatric drugs * Oral films: developing a paediatric friendly pharmaceutical product Dr Nicolas Rollet, Head of Formulation and Analytical Expert – Adexpharma * Age-appropriate oral medicine for paediatric population – Better acceptability of small and mini tablets compared to oral liquid forms Caroline Viault, Pharmaceutical Development Section Head – Sanofi Audrey Jeanjean, Pharmaceutical Development Project Manager – Sanofi |
| 17:00 | End of the day |